281 related articles for article (PubMed ID: 9261384)
1. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
Nitsche F; Bell A; Rickinson A
J Virol; 1997 Sep; 71(9):6619-28. PubMed ID: 9261384
[TBL] [Abstract][Full Text] [Related]
2. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.
Tanaka M; Yokoyama A; Igarashi M; Matsuda G; Kato K; Kanamori M; Hirai K; Kawaguchi Y; Yamanashi Y
J Virol; 2002 Feb; 76(3):1025-32. PubMed ID: 11773378
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
Harada S; Kieff E
J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
[TBL] [Abstract][Full Text] [Related]
4. Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation.
Yokoyama A; Tanaka M; Matsuda G; Kato K; Kanamori M; Kawasaki H; Hirano H; Kitabayashi I; Ohki M; Hirai K; Kawaguchi Y
J Virol; 2001 Jun; 75(11):5119-28. PubMed ID: 11333893
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
McCann EM; Kelly GL; Rickinson AB; Bell AI
J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.
Kawaguchi Y; Nakajima K; Igarashi M; Morita T; Tanaka M; Suzuki M; Yokoyama A; Matsuda G; Kato K; Kanamori M; Hirai K
J Virol; 2000 Nov; 74(21):10104-11. PubMed ID: 11024139
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E
J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
[TBL] [Abstract][Full Text] [Related]
9. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
Peng R; Tan J; Ling PD
J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
Tierney RJ; Kao KY; Nagra JK; Rickinson AB
J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
[TBL] [Abstract][Full Text] [Related]
11. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
Harada S; Yalamanchili R; Kieff E
J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
[TBL] [Abstract][Full Text] [Related]
13. Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization.
Igarashi M; Kawaguchi Y; Hirai K; Mizuno F
J Gen Virol; 2003 Feb; 84(Pt 2):319-327. PubMed ID: 12560563
[TBL] [Abstract][Full Text] [Related]
14. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.
Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K
Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.
Han I; Xue Y; Harada S; Orstavik S; Skalhegg B; Kieff E
Mol Cell Biol; 2002 Apr; 22(7):2136-46. PubMed ID: 11884601
[TBL] [Abstract][Full Text] [Related]
17. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
Cohen JI; Wang F; Kieff E
J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
[TBL] [Abstract][Full Text] [Related]
19. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
Lin J; Johannsen E; Robertson E; Kieff E
J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]